FDA Approves Bayer’s Kerendia for Chronic Kidney D...
Category : Approval/Launch 22 September 2026Bayer has announced that the U.S. Food and Drug Administration (FDA) has approved Kerendia (finereno...
Approval Launch
Glenmark Launches Calcium Gluconate Injection in t...
Category : Approval/Launch 22 August 2026New Injectable Product Targets the U.S. Institutional Healthcare Market Glenmark Pharmaceuticals...
Ultragenyx Gets FDA Accelerated Approval for Gengl...
Category : Approval/Launch 21 August 2026First Approved Therapy From Ultragenyx Directly Targets the Root Cause of GSDIa Ultragenyx Pharma...
Lupin Receives U.S. FDA Approval for Sodium Zircon...
Category : Approval/Launch 11 August 2026New Generic Treatment Approved for Hyperkalemia in Adults Lupin Limited has received approval fro...
Merck Seeks FDA Approval to Expand Enflonsia Use f...
Category : Approval/Launch 7 August 2026FDA Accepts Supplemental Application for Enflonsia Merck, known as MSD outside the United States...
Latest Newsletter Post
-
Takeda announces positive data from..
1 October 2026
-
Vanda Reports Positive Phase III Re..
30 September 2026
-
Airway Therapeutics Receives $1.9 M..
30 September 2026
-
Tolerance Bio Licenses TLB-33 From..
30 September 2026
-
Ascletis Reports Positive Phase I R..
29 September 2026
